ENTITY
JOINN Laboratories

JOINN Laboratories (6127 HK)

150
Analysis
Health Care • China
JOINN Laboratories is a specialized drug development outsourcing company (CRO) that provides non-clinical pharmacology and toxicology research and evaluation services, including drug safety assessment, pharmacodynamic, and pharmacokinetic studies. The company also offers clinical trial services and the production and sale of experimental models. Headquartered in Beijing, China, it was founded in 1995.
more
bullish•JOINN Laboratories
•25 Feb 2021 17:41

JOINN Laboratories IPO: Trading Debut

The grey market price varies from HK$146.70-HK$142.00 per H-share vs listing price of HK$151. JOINN is fairly priced at the H-share listing price...

Logo
537 Views
Share
bearish•JOINN Laboratories
•25 Feb 2021 15:12

Joinn Lab (ę˜­č”ę–°čÆ) A+H Trading: Fall in A-Share Limits the Upside

In this note, we look at updates since our last note. We think the deal attracted strong demands but its upside is capped by its A-share prices.

Logo
507 Views
Share
bullish•Tencent
•21 Feb 2021 10:22

ECM Weekly (21 February 2021) - Tencent Lock-Up Expiry, SciClone Pharma, Joinn Lab, Bairong, Betta

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
bullish•JOINN Laboratories
•17 Feb 2021 01:43

JOINN Laboratories IPO: Valuation Insights

JOINN has launched its HK IPO at an indicative price range of HK$133-151 per H-share. The combination of a reasonable AH discount and relative...

Logo
556 Views
Share
bullish•JOINN Laboratories
•16 Feb 2021 13:19

Joinn Lab (ę˜­č”ę–°čÆ) A+H: Visible Upside

There is clear upside from the high end with strong line-up of cornerstone investors. There will also be plenty of shares for institutional...

Logo
598 Views
Share
x